EP 3200774 A1 20170809 - TRANSDERMAL THERAPEUTIC SYSTEM WITH ROTIGOTINE FOR THE TREATMENT OF PARKINSON'S DISEASE
Title (en)
TRANSDERMAL THERAPEUTIC SYSTEM WITH ROTIGOTINE FOR THE TREATMENT OF PARKINSON'S DISEASE
Title (de)
TRANSDERMALES THERAPEUTISCHES SYSTEM MIT ROTIGOTIN ZUR BEHANDLUNG VON MORBUS PARKINSON
Title (fr)
SYSTÈME THÉRAPEUTIQUE TRANSDERMIQUE À BASE DE ROTIGOTINE POUR TRAITER LA MALADIE DE PARKINSON
Publication
Application
Priority
- DE 102014114282 A 20141001
- EP 2015072522 W 20150930
Abstract (en)
[origin: WO2016050824A1] The invention relates to a transdermal therapeutic system (TTS) comprising a rotigotine-containing micro-emulsion, and to a method for producing said transdermal therapeutic system and to the use of the transdermal therapeutic system for the treatment of Parkinson's disease. The TTS according to the invention has surprisingly good adhesive properties while demonstrating sustained active ingredient release.
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/381 (2006.01)
CPC (source: EP)
A61K 9/7053 (2013.01); A61K 31/381 (2013.01); A61P 25/16 (2017.12)
Citation (search report)
See references of WO 2016050824A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DE 102014114282 A1 20160407; EP 3200774 A1 20170809; WO 2016050824 A1 20160407
DOCDB simple family (application)
DE 102014114282 A 20141001; EP 15775423 A 20150930; EP 2015072522 W 20150930